4-Hydroxyphenyllactic Acid

Most routine lab panels give you no window into how your body processes the amino acids in your protein, or what your gut bacteria are doing with them. 4-HPLA (4-hydroxyphenyllactic acid) is one of the few urine markers that touches both questions at once.

This is a research-grade marker, not a guideline-driven screening test. It sits in the same family as the organic acids used to investigate inherited metabolic conditions, bacterial overgrowth in the gut, and certain liver problems. A single number does not deliver a diagnosis, and there are no professional society recommendations for using it as a routine monitoring tool in healthy adults.

What This Marker Actually Reflects

4-HPLA is built from tyrosine, an amino acid you get from protein. Your own cells generate small amounts as part of normal tyrosine breakdown. Gut bacteria can also make it from the same starting material, which means the level in your urine is a mix of two signals: how well your body is handling tyrosine internally, and what your gut microbes are doing on the outside.

The molecule comes in two mirror-image forms (called L and D). The L-form is what human metabolism produces. The D-form is almost entirely made by bacteria. In people with inherited tyrosine disorders such as tyrosinaemia, the urine 4-HPLA is purely L-form. In people without those disorders but with significant bacterial activity in the gut, a notable share of the 4-HPLA in urine is the D-form, pointing to a microbial source rather than a metabolic one.

Why Your Tyrosine Pathway Matters

Tyrosine sits at the start of several important pathways, including the chemistry your body uses to make thyroid hormone, dopamine, and pigments in skin and eyes. When that processing stalls, intermediates like 4-HPLA can build up and spill into urine. The clearest examples come from inherited disorders, but even adults without a diagnosed condition can produce more 4-HPLA when liver function is reduced or when certain treatments push the tyrosine pathway off balance.

In neonatal intrahepatic cholestasis caused by citrin deficiency (a treatable inherited liver condition affecting infants), urine 4-HPLA has been reported as a useful marker. One 2025 study reported that it separated affected infants from healthy infants with an area under the curve of 0.954 (where 1.0 would be a perfect test and 0.5 would be a coin flip). Other sources, including the GeneReviews entry for citrin deficiency, describe 4-HPLA as variably elevated depending on age and disease stage, so the marker on its own is not a stand-alone diagnostic test for this disorder.

The Gut Bacteria Angle

Some gut bacteria, including certain Bifidobacterium species, convert tyrosine directly into 4-HPLA. In infants, this microbial pathway is part of normal early-life gut development. In adults, persistently elevated bacterial 4-HPLA has been described in settings of substantial bacterial amino acid fermentation in the gut, although the data are limited and routine adult monitoring is not part of clinical practice.

The clearest documented case involved short bowel syndrome, where extensive bacterial amino acid fermentation produced large amounts of the D-form of 4-HPLA in urine. The marker became a fingerprint of what was happening in the gut, distinguishable from inherited metabolic causes only by looking at which mirror-image form was present.

Liver Disease and Cholestasis

Your liver is the main site where tyrosine breakdown is completed. When liver function drops, intermediates like 4-HPLA accumulate and get excreted in urine. Studies of cirrhosis have found increased urinary excretion of phenolic acids in this group, including 4-HPLA, which has been suggested as a way to track liver metabolizing function and the kind of blood rerouting (portal-systemic shunting) that happens in advanced liver disease.

What this means for you: if your 4-HPLA is high and you do not have a known inherited disorder, looking at standard liver markers alongside it (such as ALT, AST, GGT, and bilirubin) helps separate a liver story from a gut-microbe story.

Reading the Evidence Honestly

Most of the strongest performance data for 4-HPLA comes from sample types other than urine. In cerebrospinal fluid, one study reported an area under the curve of 0.91 for diagnosing secondary bacterial meningitis. In serum, a small study reported an unusually high area under the curve of 0.99 for predicting ICU mortality, a result that warrants skepticism because single-biomarker performance that high typically reflects a small sample size or overfitting and has not been replicated. In plasma, levels were roughly twice as high in people with hepatocellular carcinoma compared to controls (1.41 versus 0.63 micromoles per liter, a unit for very small concentrations in blood).

These findings are biologically interesting but were measured in different body fluids than this urine test. The urine version of the marker has not been directly validated for any of these uses in adults. Treat the urine measurement as exploratory rather than diagnostic, and pair it with other tests before concluding anything serious.

Putting a Result in Context

Because there are no standardized clinical cutpoints for adult urine 4-HPLA and no guideline endorsing it as a routine monitoring tool, a single reading carries limited weight on its own. It is most useful when interpreted alongside other markers, your symptoms, and your clinical history rather than as a stand-alone number.

If you are working through a specific clinical question (a suspected gut issue, a liver concern, or follow-up on an inherited tyrosine disorder) with a clinician, a repeat measurement can help confirm whether a finding is persistent or transient. In the absence of a specific question, there is no evidence that serial monitoring in otherwise healthy adults adds value.

When Results Can Be Misleading

• Recent high-protein meals: because 4-HPLA comes from tyrosine, a heavy protein load in the hours before collection can transiently raise output. Collect a first-morning sample after a typical eating day, not a steak-and-protein-shake day.
• Acute illness or critical conditions: infections, sepsis, and recent surgery have been shown to shift aromatic metabolites including 4-HPLA. A reading taken while you are sick or recovering may not represent your normal state.
• Hydration and collection timing: urine concentration affects most organic acid readings. Most labs normalize values to creatinine in your urine to correct for this, but extreme over- or under-hydration around the collection can still produce noisier numbers.
• Inability to distinguish source on most assays: standard testing typically reports total 4-HPLA without separating the human-made form from the bacteria-made form. A high result on its own does not tell you whether the source is your metabolism or your microbes.

What to Do With an Out-of-Pattern Result

An unexpectedly high 4-HPLA is a prompt to investigate, not a diagnosis. The most useful next steps depend on the rest of your clinical picture.

• If you have GI symptoms: discuss the result with a clinician. Depending on your symptoms, they may order a comprehensive stool analysis or further gut workup, although a direct link between urinary 4-HPLA and a specific gut diagnosis has not been established.
• If you have signs of liver strain: check ALT (alanine aminotransferase), AST (aspartate aminotransferase), GGT (gamma-glutamyl transferase), bilirubin, and bile acid testing. Liver involvement can push 4-HPLA up.
• If you have a family history of inherited metabolic disorders: consult a metabolic specialist. Adult-onset presentations of tyrosinaemia and related conditions are rare but exist, and they require specific workup beyond a single organic acid result.
• If everything else looks normal: discuss with your clinician whether retesting under controlled conditions (consistent diet, no acute illness, normal hydration) is worthwhile, or whether the finding can simply be observed.